EMA lifts drug export ban on Ranbaxy's Toansa manufacturing plant
15th June 2014
The European Medicines Agency (EMA) has lifted suspension imposed on export of drugs produced at Ranbaxy Laboratories’ Toansa manufacturing site in India.
European regulatory authorities have finalized their assessment of reported non-compliance with Good Manufacturing Practice (GMP) at Toansa site that had led to the suspension of the GMP certificate for the site in the European Union (EU).
Read more at source article www.pbr.com